Merit Medical Systems (NASDAQ:MMSI) Hits New 52-Week Low – Should You Sell?

Merit Medical Systems, Inc. (NASDAQ:MMSI)’s share price reached a new 52-week low during trading on Friday . The stock traded as low as $67.17 and last traded at $67.4550, with a volume of 85674 shares changing hands. The stock had previously closed at $68.33.

Analyst Ratings Changes

MMSI has been the subject of several recent research reports. Barrington Research increased their price objective on Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. BTIG Research initiated coverage on Merit Medical Systems in a research note on Friday, February 6th. They issued a “buy” rating and a $107.00 target price on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Merit Medical Systems in a research report on Monday, December 29th. Needham & Company LLC cut their price target on Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating for the company in a research note on Wednesday, February 25th. Finally, Robert W. Baird set a $108.00 price target on Merit Medical Systems in a report on Tuesday, December 16th. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $103.33.

Merit Medical Systems Price Performance

The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95. The stock has a market capitalization of $3.96 billion, a P/E ratio of 31.47, a PEG ratio of 1.93 and a beta of 0.62. The stock’s fifty day moving average is $78.19 and its 200-day moving average is $83.03.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.08. The company had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The business’s revenue was up 10.9% compared to the same quarter last year. During the same period last year, the company earned $0.93 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, equities analysts anticipate that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current year.

Institutional Investors Weigh In On Merit Medical Systems

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Los Angeles Capital Management LLC acquired a new position in Merit Medical Systems during the fourth quarter valued at approximately $25,000. Maseco LLP bought a new position in shares of Merit Medical Systems in the fourth quarter valued at approximately $26,000. Salomon & Ludwin LLC acquired a new stake in shares of Merit Medical Systems in the third quarter worth $37,000. Torren Management LLC bought a new stake in shares of Merit Medical Systems during the 4th quarter worth $38,000. Finally, Covestor Ltd boosted its holdings in shares of Merit Medical Systems by 252.6% during the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 336 shares during the period. 99.66% of the stock is currently owned by institutional investors and hedge funds.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.